|
Volumn Spec No, Issue , 2006, Pages 20-26
|
Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
CATARACT;
CHEMICALLY INDUCED DISORDER;
DRUG CONTRAINDICATION;
DYSKINESIA;
EXTRAPYRAMIDAL SYNDROME;
HEART ARRHYTHMIA;
HUMAN;
HYPERLIPIDEMIA;
HYPERPROLACTINEMIA;
MYOCARDITIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
SCHIZOPHRENIA;
SEXUAL DYSFUNCTION;
WEIGHT GAIN;
ANTIPSYCHOTIC AGENTS;
ARRHYTHMIA;
BASAL GANGLIA DISEASES;
CATARACT;
DIABETES MELLITUS, TYPE 2;
DYSKINESIA, DRUG-INDUCED;
HUMANS;
HYPERLIPIDEMIAS;
HYPERPROLACTINEMIA;
MYOCARDITIS;
OBESITY;
SCHIZOPHRENIA;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
WEIGHT GAIN;
|
EID: 33751540060
PISSN: 00325481
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (19)
|
References (38)
|